http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111529528-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 |
| filingDate | 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111529528-B |
| titleOfInvention | Pharmaceutical composition for treating ulcerative colitis |
| abstract | The invention relates to a pharmaceutical composition for treating ulcerative colitis, which consists of effective components and medically acceptable auxiliary materials, and is characterized in that the effective components consist of the following raw materials in percentage by weight: 30-60% of Nodosin and 40-70% of quassine F. The effective components of Nodosin and picrasma quassioides F in the pharmaceutical composition of the invention show obvious synergistic effect in the aspect of treating ulcerative colitis, so the effect of treating ulcerative colitis is obvious. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114515302-A |
| priorityDate | 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.